We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 688 results
  1. Lysergic Acid Diethylamide (LSD) for the Treatment of Anxiety Disorders: Preclinical and Clinical Evidence

    Anxiety disorders (ADs) represent the sixth leading cause of disability worldwide, resulting in a significant global economic burden. Over 50% of...

    Antonio Inserra, Alexandre Piot, ... Gabriella Gobbi in CNS Drugs
    Article 21 August 2023
  2. The effects of Lysergic Acid Diethylamide (LSD) on the Positive Valence Systems: A Research Domain Criteria (RDoC)-Informed Systematic Review

    Background and Objectives

    The renewed interest in psychedelic research provides growing evidence of potentially unique effects on various aspects of...

    Niloufar Pouyan, Farnaz Younesi Sisi, ... Jonathan D. Morrow in CNS Drugs
    Article Open access 24 November 2023
  3. The effect of lysergic acid diethylamide (LSD) on whole-brain functional and effective connectivity

    Psychedelics have emerged as promising candidate treatments for various psychiatric conditions, and given their clinical potential, there is a need...

    Peter Bedford, Daniel J. Hauke, ... Andreea O. Diaconescu in Neuropsychopharmacology
    Article Open access 25 April 2023
  4. Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants

    Mescaline, lysergic acid diethylamide (LSD), and psilocybin are classic serotonergic psychedelics. A valid, direct comparison of the effects of these...

    Laura Ley, Friederike Holze, ... Matthias E. Liechti in Neuropsychopharmacology
    Article Open access 25 May 2023
  5. Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects

    Growing interest has been seen in using lysergic acid diethylamide (LSD) and psilocybin in psychiatric research and therapy. However, no modern...

    Friederike Holze, Laura Ley, ... Matthias E. Liechti in Neuropsychopharmacology
    Article Open access 25 February 2022
  6. Repeated lysergic acid diethylamide (LSD) reverses stress-induced anxiety-like behavior, cortical synaptogenesis deficits and serotonergic neurotransmission decline

    Lysergic acid diethylamide (LSD) is a serotonergic psychedelic compound receiving increasing interest due to putative anxiolytic and antidepressant...

    Danilo De Gregorio, Antonio Inserra, ... Gabriella Gobbi in Neuropsychopharmacology
    Article 17 March 2022
  7. Low doses of lysergic acid diethylamide (LSD) increase reward-related brain activity

    Renewed interest in classic psychedelics as treatments for psychiatric disorders warrants a deeper understanding of their neural mechanisms. Single,...

    James Glazer, Conor H. Murray, ... Harriet de Wit in Neuropsychopharmacology
    Article 25 October 2022
  8. Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects

    Growing interest has been seen in using lysergic acid diethylamide (LSD) in psychiatric research and therapy. However, no modern studies have...

    Friederike Holze, Patrick Vizeli, ... Matthias E. Liechti in Neuropsychopharmacology
    Article Open access 15 October 2020
  9. Perceived risk of LSD varies with age and race: evidence from 2019 United States cross-sectional data

    Purpose

    Psychedelics are being explored for their potential therapeutic benefits across a wide range of psychiatric diagnoses and may usher in a new...

    Nicholas L. Bormann, Andrea N. Weber, ... Alison C. Lynch in Social Psychiatry and Psychiatric Epidemiology
    Article 06 March 2023
  10. Identification of 1-(thiophene-2-carbonyl)-LSD from blotter paper falsely labeled “1D-LSD”

    Purpose

    Since the mid-2010s, lysergic acid diethylamide (LSD) analogs made for substance abuse have periodically emerged. In this case, three pieces...

    Yuki Okada, Kazuki Ueno, ... Yuko T. Iwata in Forensic Toxicology
    Article 08 July 2023
  11. Early-onset alcohol, tobacco, and illicit drug use with age at onset of hypertension: a survival analysis

    Purpose

    To examine the associations of age when first substance use and early-onset substance use before age 18 with age at onset (AAO) of...

    Kesheng Wang, Saima Shafique, ... Erin L. Winstanley in Social Psychiatry and Psychiatric Epidemiology
    Article 16 December 2023
  12. Neural complexity is increased after low doses of LSD, but not moderate to high doses of oral THC or methamphetamine

    Neural complexity correlates with one’s level of consciousness. During coma, anesthesia, and sleep, complexity is reduced. During altered states,...

    Conor H. Murray, Joel Frohlich, ... Harriet de Wit in Neuropsychopharmacology
    Article 29 January 2024
  13. Acute effects of MDMA and LSD co-administration in a double-blind placebo-controlled study in healthy participants

    Abstract

    There is renewed interest in the use of lysergic acid diethylamide (LSD) in psychiatric research and practice. Although acute subjective...

    Isabelle Straumann, Laura Ley, ... Matthias E. Liechti in Neuropsychopharmacology
    Article Open access 31 May 2023
  14. Dose-response relationships of LSD-induced subjective experiences in humans

    Lysergic acid diethylamide (LSD) is a potent classic serotonergic psychedelic, which facilitates a variety of altered states of consciousness. Here...

    Tim Hirschfeld, Johanna Prugger, ... Timo T. Schmidt in Neuropsychopharmacology
    Article Open access 09 May 2023
  15. The Therapeutic Effects of Classic Psychedelics in Alcohol Use Disorder

    Purpose of review

    This article utilizes a pre-existing framework in the field of addiction to comprehensively capture the effects of classic...

    B. A Pagni, J Wong, M. P Bogenschutz in Current Addiction Reports
    Article 25 June 2024
  16. Identification of LSD analogs, 1cP-AL-LAD, 1cP-MIPLA, 1V-LSD and LSZ in sheet products

    Purpose

    Many analogs of lysergic acid diethylamide (LSD) have recently appeared as designer drugs around the world. These compounds are mainly...

    Rie Tanaka, Maiko Kawamura, ... Ruri Kikura-Hanajiri in Forensic Toxicology
    Article Open access 21 February 2023
  17. High-sensitivity method for the determination of LSD and 2-oxo-3-hydroxy-LSD in oral fluid by liquid chromatography‒tandem mass spectrometry

    Purpose

    We have developed and validated a high-sensitivity method to quantify lysergic acid diethylamide (LSD) and 2-oxo-3-hydroxy-LSD (OH-LSD) in...

    Kelly Francisco da Cunha, Julia Martinelli Magalhães Kahl, ... Jose Luiz Costa in Forensic Toxicology
    Article 12 April 2022
  18. Neurobiology of the Antidepressant Effects of Serotonergic Psychedelics: A Narrative Review

    Purpose of Review

    Serotonergic psychedelics include psilocybin, lysergic acid diethylamide (LSD), dimethyltryptamine (DMT), and other agonists of the...

    Noah Chisamore, Erica Kaczmarek, ... Joshua D. Rosenblat in Current Treatment Options in Psychiatry
    Article 26 April 2024
  19. LSD increases sleep duration the night after microdosing

    Microdosing psychedelic drugs at a level below the threshold to induce hallucinations is an increasingly common lifestyle practice. However, the...

    Nathan Allen, Aron Jeremiah, ... Partha Roop in Translational Psychiatry
    Article Open access 15 April 2024
Did you find what you were looking for? Share feedback.